Compare ZVRA & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | TTGT |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1850 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.9M | 416.4M |
| IPO Year | 2015 | 2024 |
| Metric | ZVRA | TTGT |
|---|---|---|
| Price | $10.10 | $5.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $23.00 | $10.75 |
| AVG Volume (30 Days) | ★ 712.5K | 498.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.21 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $106,470,000.00 | N/A |
| Revenue This Year | $37.27 | $4.45 |
| Revenue Next Year | $53.42 | $2.75 |
| P/E Ratio | $7.46 | ★ N/A |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $3.41 |
| 52 Week High | $13.16 | $9.00 |
| Indicator | ZVRA | TTGT |
|---|---|---|
| Relative Strength Index (RSI) | 52.59 | 72.11 |
| Support Level | $8.25 | $5.44 |
| Resistance Level | $11.07 | $6.43 |
| Average True Range (ATR) | 0.41 | 0.35 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 39.32 | 87.67 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.